Here’s what you should know:
1. After fees, Exact Sciences will make approximately $238 million.
2. Several investment firms can sell up to 1.05 million more shares of Exact Sciences if buyers demand it.
3. As of April 29, Exact Sciences had 111.2 million shares of common stock.
More articles on gastroenterology:
CEO compensation for 10 GI companies for the last 3 years
Gastroenterologists ignoring H.pylori guidelines, survey says
5 stats on GI net revenue per case at multispecialty ASCs
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.